The World Health Organisation (WHO) confirmed on Wednesday that three new drugs are undergoing clinical trials in a bid to find effective treatments for COVID-19.
The WHO Director-General, Dr. Tedros Ghebreyesus, who disclosed this at a press conference in Geneva, Switzerland, listed the drugs as Artesunate, Imatinib and Infliximab.
The drugs, according to him, will be tested on COVID-19 patients in 52 countries across the world under the Solidarity PLUS programme.
The WHO chief revealed that there are 203 million confirmed COVID-19 cases across the world.
